Last updated: October 10, 2022
Sponsor: N.N. Petrov National Medical Research Center of Oncology
Overall Status: Active - Recruiting
Phase
N/A
Condition
Colorectal Cancer
Colon Cancer
Treatment
N/AClinical Study ID
NCT05468827
ISC-1
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Pathologically confirmed adenocarcinoma of colon (caecum, ascending colon, hepaticflexure, transverse colon, splenic flexure, descending colon, sigmoid)
- TNM T1-4a N0-2 M0-1
- Clinical indications to colonic resection
- ECOG - 0-2
- Signed informed consent.
Exclusion
Exclusion Criteria:
- Medical or psychiatric reasons interfering with patient's decision to participate inthe study.
- Pregnancy or breastfeeding.
- Medical conditions contraindicating surgical procedure.
- Acute bowel obstruction, bleeding or perforation.
- Hypersensitivity to indocyanine green, sodium iodide or iodine
- Hyperthyroidism or autonomic thyroid adenomas
- Kidney failure of any aetiology
- Hepatic failure of any aetiology
- Poorly tolerated indocyanine injection in the past.
Study Design
Total Participants: 100
Study Start date:
July 26, 2022
Estimated Completion Date:
July 31, 2024
Study Description
Connect with a study center
N.N. Petrov National Medical Research Center of Oncology
Saint Petersburg, 192289
Russian FederationActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.